scholarly journals SEARCH OF NEW PHARMACEUTICALS ON THE BASIS OF DARBEPOETIN IN THE TREATMENT OF ISCHEMIC STROKE (REVIEW OF LITERATURE)

Author(s):  
K.M. Reznikov ◽  
◽  
N.S. Gorbunova ◽  
P.D. Kolesnichenko ◽  
A.V. Tverskoy ◽  
...  
2010 ◽  
Vol 64 (8) ◽  
pp. 385 ◽  
Author(s):  
VS Ramalingam ◽  
S Sudhakar ◽  
R Sinnakirouchenan ◽  
AV Brasch

Cureus ◽  
2018 ◽  
Author(s):  
Shishir K Rao ◽  
Owais Ahmad ◽  
Farzana Tariq ◽  
Kushak Suchdev ◽  
Sandeep Mittal ◽  
...  

1970 ◽  
Vol 6 (2) ◽  
pp. 114-116
Author(s):  
M Maksumul Haq ◽  
Sahela Nasrin ◽  
Syed Dawood Md Taimur ◽  
Hemanta I Gomes ◽  
Mohammad Arifur Rahman

We report a case of 73 year old woman with known risk factor (hypertension) for cerebrovascular disease who developed a TIA like symptom & vertigo with spontaneous clinical improvement. CT showed left cerebral infarct. Haematological test revealed PRV. Clinical improvement was associated with a reduction in haematocrit levels. Hydroxyurea appears to be the least leukemogenic myelosuppressive agent in long term prospective clinical PRV studies extending observation period of >10 years. Low dose aspirin will prevent the microvascular thrombotic complications of thrombocythaemia associated with PRV in remission after phlebotomy.Key words: Polycythaemia Rubra Vera(PRV); Thrombosis; Ischemic stroke DOI: 10.3329/uhj.v6i2.7259University Heart Journal Vol. 6, No. 2, July 2010 pp.114-116


2017 ◽  
Vol 26 (8) ◽  
pp. e153-e155 ◽  
Author(s):  
Guillaume Fargeot ◽  
Sabrina Stefanizzi ◽  
Sebastien Depuydt ◽  
Frederic Klapczynski ◽  
Alain Ameri

2015 ◽  
Vol 36 (7) ◽  
pp. 1097-1103 ◽  
Author(s):  
Rong Li ◽  
Chen Huang ◽  
Jian Chen ◽  
Yang Guo ◽  
Sheng Tan

Sign in / Sign up

Export Citation Format

Share Document